Compliance monitoring of NSAID drug therapy in ankylosing spondylitis, experiences with an electronic monitoring device

British Journal of Rheumatology

Volumn 35, Issue 1, 1996, Pages 60-65

  De Klerk, E ^a   Van Der Linden, S J ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Ankylosing spondylitis; NSAIDs; Patient compliance

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; TENOXICAM;

ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0029933446     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/35.1.60     Document Type: Article

References (23)

1. Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. Am J Hosp Pharm 1991;48:1978-88.
2. Cramer JA, Spilker B (eds) Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991.
3. Harter JG, Peck CC. Chronobiology: suggestions for integrating it into drug development. Ann NY Acad Sci 1991;618:563-71.
4. Efron B, Feldman D. Compliance as an explanatory variable in clinical trials. J Am Stat Assoc 1991;413:9-17.
5. Goetghebeur EJT, Pocock SJ. Statistical issues in allowing for noncompliance and withdrawal. Drug Information J 1993;27:837-45.
6. Urquhart J. Variable patient compliance in ambulatory trials nuisance, threat, opportunity. J Antimicrob Chemother 1993;32:643-9.
7. Levy G. A pharmacokinetic perspective on medicament noncompliance. Clin Pharmacol Ther 1993;54:242-4.
8. Rubin D. Comment: dose response estimands. J Am Stat Assoc 1991;413:22-4.
9. Zeger SL, Liang K-Y. Comment: dose-response estimands. J Am Stat Assoc 1991;413:18-9.
10. Urquhart J. Patient compliance as an explanatory variable in four selected cardiovascular studies. In: Cramer JA, Spilker B, eds. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991.
11. The Lipid Research Clinics Coronary Primary Prevention Trial results: (I) Reduction in incidence of coronary heart disease; (II) The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. J Am Med Assoc 1984;251:351-74.
12. Manninen V, Elo MO, Frick H et al. Lipid alternations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. J Am Med Assoc 1988;260:641-51.
13. Vander Stichele R. Measurement of patient compliance and the interpretation of randomized clinical trials. Eur J Clin Pharmacol 1991;41:27-35.
14. Kruse W. Patient compliance with drug treatment - new perspectives on an old problem. Clin Invest 1992;70:163-6.
15. Pullar T, Feely M. Problems of compliance with drug treatment: new solutions? Pharm J 1990;245:213-5.
16. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Ouellette VL. How often is medication taken as prescribed? A novel assessment technique. J Am Med Assoc 1989;261:3273-7.
17. Averbuch M, Weintraub M, Pollack DJ. Compliance assessment in clinical trials: the MEMS device. J Clin Res Pharmacoepidemiol 1990;4:199-204.
18. van der Linden S, Valkenburg HA. Evaluation of diagnostic criteria for Ankylosing Spondylitis: A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
19. Gonzales JP, Todd PA. Tenoxicam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 1987;34:289-310.
20. Todd PA, Clissold SP. Tenoxicam, an update of its pharmacology and therapeutic efficacy in rheumatic diseases. Drugs 1991;41:625-46.
21. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990;150:1509-10.
22. Probstfield JL. Clinical trial prerandomization compliance (adherence) screen. In: Cramer JA, Spilker B, eds. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991.
23. Hasford J. Biometric issues in measuring and analyzing partial compliance in clinical trials. In: Cramer JA, Spilker B, eds. Patient compliance in medical practice and clinical trials. New York: Raven Press, 1991.